Plasma exchange in children with kidney disease
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks back at kids aged 1–18 who had a treatment called therapeutic plasma exchange (TPE) in the pediatric kidney unit. TPE is a procedure that replaces the liquid part of the blood, which may help with certain kidney conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 1 and 18 years old.
- You must have had a blood-filtering treatment called therapeutic plasma exchange (TPE).
- You must be able to have a central line placed (a small tube in a large vein).
- You must not have an active infection or unstable blood pressure.
- You must not have allergies to fresh frozen plasma (blood product) or albumin (a protein solution).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether removing harmful substances from the blood (plasma exchange) can help children with severe infections that cause organ failure or very low blood pressure. If your child is in the hospital with severe sepsis or septic shock and is between 1 month and 18 years old, this treatment might be an option.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
This trial tests whether plasma exchange (a procedure that cleans the blood) can help children with a severe form of autoimmune encephalitis—a condition where the immune system attacks the brain. It's for children who haven't gotten better with standard treatments like steroids or IVIG.
This study looks at whether removing and replacing blood plasma (called therapeutic plasma exchange or TPE) can help people with immune-related nerve or brain conditions. It includes both new and returning cases that meet standard guidelines for this treatment.
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
Hear when a new Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.